Loading…
Addex Therapeutics Ltd is projected to rise to $5.07 by 2027, a 0% move from its current price of $5.06. ADXN is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $4.89 | $5.06 | $5.24 | +0.05% |
| Aug 6 | $4.83 | $5.06 | $5.31 | +0.10% |
| Aug 7 | $4.78 | $5.07 | $5.37 | +0.15% |
| Aug 8 | $4.74 | $5.07 | $5.42 | +0.19% |
| Aug 9 | $4.70 | $5.07 | $5.47 | +0.24% |
| Aug 10 | $4.67 | $5.07 | $5.51 | +0.29% |
| Aug 11 | $4.64 | $5.08 | $5.55 | +0.34% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.64 | $5.08 | $5.55 | +0.34% |
| Week 2 | $4.49 | $5.09 | $5.78 | +0.68% |
| Week 3 | $4.38 | $5.11 | $5.97 | +1.02% |
| Week 4 | $4.29 | $5.13 | $6.13 | +1.36% |
| Week 5 | $4.21 | $5.15 | $6.28 | +1.71% |
| Week 6 | $4.15 | $5.16 | $6.43 | +2.05% |
| Week 7 | $4.09 | $5.18 | $6.56 | +2.40% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes. Its lead programs include Dipraglurant, which is in phase 1 clinical trial for the treatment of post-stroke/TBI recovery, as well as to treat Parkinson's disease levodopa-induced dyskinesia.
It also develops ADX71149, which is in phase 1 for undisclosed indication; and GABAB PAM for the treatment pain, anxiety, addiction, chronic cough, and overactive bladder. It has license and collaboration agreement with Janssen Pharmaceuticals Inc. for the develop mGlu2 PAM compounds for the treatment of human health; and license and research agreement with Indivior PLC discovery, development, and commercialization of novel GABAB PAM compounds for the treatment of addiction and other CNS diseases.
The company was formerly known as Addex Pharmaceuticals Ltd. Addex Therapeutics Ltd was founded in 2002 and is based in Geneva, Switzerland.
ADXN is a healthcare company with a focus on neurological disorders. The current price is $5.20 and the market capitalization is $6.58M. It is ranked 5199.
A major floor 14.6% below — a decisive break under it would weaken the trend.
Price is testing support right now (2.8% away) — a key level to hold.
The nearest ceiling, 28.9% above — a clean break opens room to run.
A major ceiling 42.3% above — clearing it would confirm fresh momentum.
Key ADXN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ADXN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.69 | Sell | $5.59 | Sell |
| MA 10 | $5.76 | Sell | $5.71 | Sell |
| MA 20 | $5.83 | Sell | $5.82 | Sell |
| MA 50 | $6.13 | Sell | $6.08 | Sell |
| MA 100 | $6.40 | Sell | $6.45 | Sell |
| MA 200 | $7.26 | Sell | $7.01 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 33.60 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -286.01 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.03 | Sell |
| ROC (12) | -15.93 | Sell |
| Bollinger %B (20,2) | -0.22 | Buy |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.26 | Sell |
| Awesome (5,34) | -0.25 | Sell |
| Ultimate (7,14,28) | 15.73 | Buy |
| Momentum (10) | -0.50 | Sell |
| Aroon Osc (25) | -60.00 | Sell |
| Hull MA (9) | 5.56 | Sell |
| ADX (14) | 11.58 | Neutral |
| ATR (14) | 0.16 | Info |
The 30-day technical picture is bearish. RSI14 is 30, signaling oversold conditions, with a SMA50 of $6.13 and a SMA200 of $7.26.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $5.06 | $5.06 | $6.55 | 0% | Neutral | |
| $3.96 | $5.07 | $6.91 | 0% | Neutral | |
| $4.03 | $5.36 | $7.64 | +6% | Neutral | |
| $4.55 | $6.23 | $9.20 | +23% | Bullish | |
| $5.14 | $7.22 | $10.98 | +43% | Bullish | |
| $5.70 | $8.20 | $12.79 | +62% | Bullish | |
| $5.79 | $8.52 | $13.60 | +68% | Bullish | |
| $5.67 | $8.53 | $13.90 | +69% | Bullish | |
| $5.43 | $8.34 | $13.84 | +65% | Bullish | |
| $5.31 | $8.31 | $14.03 | +64% | Bullish | |
| $7.63 | $13.06 | $23.69 | +158% | Bullish | |
| $12.53 | $25.16 | $50.59 | +397% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $5.06 | $5.06 | $6.18 | +0.00% |
| September 2026 | $4.48 | $5.33 | $6.55 | +5.40% |
| October 2026 | $4.40 | $5.29 | $6.58 | -0.84% |
| November 2026 | $4.21 | $5.09 | $6.40 | -3.83% |
| December 2026 | $4.24 | $5.16 | $6.55 | +1.45% |
Click any year to see its month-by-month ADXN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The ADXN price prediction for 2026 points to an average of $5.06 (low $5.06, high $6.55) — a potential gain of 0% on today's $5.06. Price action looks broadly range-bound.
In 2027, ADXN is projected to trade between $3.96 and $6.91, averaging $5.07 — a potential gain of 0% from today's $5.06. That is up 0% on the projected 2026 average. A consolidation phase looks the most probable path here.
Addex Therapeutics Ltd's 2028 outlook centres on $5.36, within a $4.03 to $7.64 range. That is up +6% on the projected 2027 average. That marks a +6% change versus current levels. Price action looks broadly range-bound.
By 2029, ADXN could reach as high as $9.20, with a base case around $6.23 and support toward $4.55 — roughly +23% from $5.06. Buyers look set to stay in control over this stretch.
Expect ADXN to range from $5.14 to $10.98 through 2030. The $7.22 average target implies a +43% move from current prices. That is up +16% on the projected 2029 average. Momentum favours further upside here.
The ADXN price prediction for 2031 points to an average of $8.20 (low $5.70, high $12.79) — a potential gain of +62% on today's $5.06. Buyers look set to stay in control over this stretch.
In 2032, ADXN is projected to trade between $5.79 and $13.60, averaging $8.52 — a potential gain of +68% from today's $5.06. That is up +4% on the projected 2031 average. Momentum favours further upside here.
Addex Therapeutics Ltd's 2033 outlook centres on $8.53, within a $5.67 to $13.90 range. That is up 0% on the projected 2032 average. That marks a +69% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, ADXN could reach as high as $13.84, with a base case around $8.34 and support toward $5.43 — roughly +65% from $5.06. Momentum favours further upside here.
Expect ADXN to range from $5.31 to $14.03 through 2035. The $8.31 average target implies a +64% move from current prices. That is 0% versus the projected 2034 average. Buyers look set to stay in control over this stretch.
The ADXN price prediction for 2040 points to an average of $13.06 (low $7.63, high $23.69) — a potential gain of +158% on today's $5.06. Momentum favours further upside here.
In 2050, ADXN is projected to trade between $12.53 and $50.59, averaging $25.16 — a potential gain of +397% from today's $5.06. That is up +93% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in ADXN today (≈ 197.628458 ADXN) could be worth
$4,972.34
+$3,972.34 (+397%) by 2050 · US Dollar
Based on the average projected ADXN price of $25.16 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ADXNwould be worth at today's price.
$1,000 invested in ADXN on Jul 31, 2025 (≈ 121.951222 ADXN) would be worth
$617.07
-$382.93 (-38.3%) today · 0.62× · US Dollar
Based on a ADXN entry price of $8.2 vs. today's $5.06.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.89 | $859.81 | -14.0% |
| 1 month ago | $5.72 | $884.62 | -11.5% |
| 3 months ago | $7 | $722.86 | -27.7% |
| 6 months ago | $7.66 | $660.57 | -33.9% |
| 1 year ago | $8.2 | $617.07 | -38.3% |
| All time (5.0y) ago | $198.6 | $25.48 | -97.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ADXN forecast.
Our base-case forecast reaches $10.00 around 2040.
Implied market cap at $10.00: $12.66M
The multi-year forecast shows a bullish trajectory starting in 2029, with 2029 expected to be $6.40 on average and rising thereafter. The 2030 forecast shows an average price of $7.41 and a max of $11.27 (ROI 42.5%), with continued gains through 2031–2035. By 2040, the average price is $13.40 and the max $24.29 (ROI 157.6%), and by 2050 the average price reaches $25.84 with a max of $51.95 (ROI 396.9%).
These figures reflect a shift from neutral in the near term to bullish over the longer horizon, but remain estimates rather than guarantees.
Tap a question to reveal the answer.
Avg $7.41, min $5.27, max $11.27; ROI 42.5%; sentiment BULLISH.
Forecasts show a bullish sentiment from 2029 onward, with notable upside by 2030 and beyond (e.g., 2030 Avg $7.41, max $11.27; ROI 42.5%). These are estimates, not guarantees.
Yes. The forecast shows max prices of $14.24 in 2033 and $14.44 in 2035.
Current price is $5.20 and market cap is $6.58M.
Bearish sentiment with RSI 14 at 30. The 30-day range is $4.16 to $6.50, support at $5.20 and resistance at $6.52, with volatility around 60%.
Addex Therapeutics Ltd Community Discussion
0Share your Addex Therapeutics Ltd price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.